An international journal published by Elsevier.

Is consensus in anti-aging medicine intervention An Elusive expectationIn the May-June 2009 issue of the prestigious Archives of Gerontology and Geriatrics, an international journal published by Elsevier, Imre Zs of the University of Debrecen Medical and Health Science Centre , and founder and editor-in-chief of the Archives of Gerontology and Geriatrics (presented numerous studies documenting a wide range of anti-aging medicine therapeutics that currently exist and are in clinical use today , as well as setting interventions in laboratory stage are to slow, prevent and perhaps even reverse the degenerative diseases of aging and the degenerative biological processes that illness, disability illness, disability, addiction and death..

Is the number one is the number one cause of death worldwide, but we do not know enough about the causes to reliably identify and treat cases, let alone prevent that these diseases, ‘he says. ‘In up to 95 % of cases, the causes of vascular diseases Sun Sun clinicians must rely on ‘lifestyle’ indicators and ‘risk factors’ such as high blood pressure and high cholesterol. – ‘However, not all people with high blood pressure or high cholesterol experience heart attack or stroke at the same time, many people have no obvious risk factors, unexpected heart attack and stroke We need a revolution in vascular diagnosis, treatment and prevention This discovery is an important step. The path ‘.. However, the new drug – reactivates the damaged enzyme – by Bayer HealthCare developed Our results indicate that the drug directly binds and repairs the damaged enzyme and as the number of free radicals increases, the drug starts to work harder, ‘says Dr.Connie M. Brigham and Women’s Hospital de Renal Division in Massachusetts General Hospital and colleague examined data from patient between January 1990 and June 2013, treated to non – already existing hyperthyroidism or hypothyroidism. Functional disturbances patients received a euthyroid controls, and from exposure to iodinated contrast agent was tuned based on claims data.